U.S. Markets open in 3 hrs 42 mins

Biomerica, Inc. (BMRA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.75+0.08 (+3.00%)
At close: 4:00PM EDT
People also watch
BLFSMLSSAHPICASMPDEX

Biomerica, Inc.

17571 Von Karman Avenue
Irvine, CA 92614
United States
949-645-2111
http://www.biomerica.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees35

Key Executives

NameTitlePayExercisedAge
Mr. Zackary S. IraniChairman and Chief Exec. Officer97.23kN/A51
Mr. Francis E. CapitanioPres136.56kN/A73
Ms. Janet MooreChief Financial Officer, Treasurer, Sec. and Director102.45kN/A66
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions worldwide. Its diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; and to measure the level of specific hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. The company primarily focuses on products for gastrointestinal, food intolerances, diabetes, and esoteric tests. Biomerica, Inc. offers its products hospital and clinical laboratories, medical research institutions, medical schools, pharmaceutical companies, chain drugstores, wholesalers, and physicians' offices, as well as to distributors. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.

Corporate Governance

Biomerica, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.